Genetic Testing in Patients with Autoimmune Lymphoproliferative Syndrome: Experience of 802 Patients at Cincinnati Children's Hospital Medical Center. Xu, X; Denton, J; Wu, Y; Liu, J; Guan, Q; Dawson, DB; Bleesing, J; Zhang, W. Journal of Clinical Immunology. 2024; 44:166.

COVID-19 Vaccination in Patients with Inborn Errors of Immunity Reduces Hospitalization and Critical Care Needs Related to COVID-19: a USIDNET Report. McDonnell, J; Cousins, K; Younger, ME M; Lane, A; Abolhassani, H; Abraham, RS; Al-Tamemi, S; Aldave-Becerra, JC; Al-Faris, EH; Alfaro-Murillo, A; Lim, XR; Lopes, JP; López, AL; Tarquini, L. Journal of Clinical Immunology. 2024; 44:86.

68 LRBA dysfunction: a new diagnostic entity caused by biallelic LRBA missense variants results in reduced CTLA-4 expression and autoimmunity. Chiang, S; Murguia-Favela, L; Wright, N; Steele, M; Seroogy, C; Blanchard-Rohner, G; Shrikhande, A; Wilson, J; Yang, L; Owsley, E; Derfalvi, B; Brager, R; Jordan, M; Marwaha, A. Clinical Immunology. 2024; 262:110010.

Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: A  Primary Immune Deficiency Treatment Consortium study. Grunebaum, E; Arnold, DE; Logan, B; Parikh, S; Marsh, RA; Griffith, LM; Mallhi, K; Chellapandian, D; Lim, SS; Deal, CL; Torgerson, TR; Malech, HL; Kang, EM; Leiding, JW. Journal of Allergy and Clinical Immunology. 2024; 153:1423-1431.e2.

Clinical, immunological features, treatments, and outcomes of autoimmune hemolytic anemia in patients with RAG deficiency. Wang, C; Sun, B; Wu, K; Farmer, JR; Ujhazi, B; Geier, CB; Gordon, S; Westermann-Clark, E; Savic, S; Secord, E; Wang, W; Wang, JY; Wang, X; Walter, JE. Blood Advances. 2024; 8:603-607.

Posttransplantation late complications increase over time for patients with SCID: A Primary Immune Deficiency Treatment Consortium (PIDTC) landmark study. Eissa, H; Thakar, MS; Shah, AJ; Logan, BR; Griffith, LM; Dong, H; Parrott, RE; O'Reilly, RJ; Dara, J; Kapoor, N; Haddad, E; Buckley, RH; Cowan, MJ; Heimall, J. Journal of Allergy and Clinical Immunology. 2024; 153:287-296.

Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD. Leiding, JW; Arnold, DE; Parikh, S; Logan, B; Marsh, RA; Griffith, LM; Wu, R; Kidd, S; Mallhi, K; Chellapandian, D; Pulsipher, MA; Torgerson, TR; Malech, HL; Kang, EM. Blood. 2023; 142:2105-2118.

Clinical Characteristics, Management, and Allogeneic Hematopoietic Cell Transplantation of Patients with Toll-like Receptor 8 Gain-of-Function Mutations. Arnold, DE; Kaviany, S; Aluri, J; Murguia-Favela, L; Wright, NA; Loughran, TP; Powell, J; De Ravin, SS; Rao, VK; Holland, S; Bleesing, J; Bednarski, JJ; Connelly, JA; Cooper, M. Blood. 2023; 142:936.

Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium. Thakar, MS; Logan, BR; Puck, JM; Dunn, EA; Buckley, RH; Cowan, MJ; O'Reilly, RJ; Kapoor, N; Satter, LF; Pai, SY; Griffith, LM; Haddad, E; Dvorak, CC; Notarangelo, LD. The Lancet. 2023; 402:129-140.

Autoimmune Lymphoproliferative Syndrome (ALPS) Disease and ALPS Phenotype: Are They Two Distinct Entities?. Palmisani, E; Miano, M; Grossi, A; Lanciotti, M; Lupia, M; Terranova, P; Ceccherini, I; Montanari, E; Calvillo, M; Pierri, F; Crescenzio, N; Bleesing, J; Dufour, C; Fioredda, F. HemaSphere. 2023; 7:e845.